Sildenafil Powder, For Suspension
Product Images NDC 69238-1574

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 69238-1574). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Sildenafil For Oral Suspension 1)

FDA Label Image

Figure 9 (Sildenafil For Oral Suspension 10)

FDA Label Image

Figure 10 (Sildenafil For Oral Suspension 11)

Figure 10 (Sildenafil For Oral Suspension 11)
Patient prescribed Sicansti 20 mg to be taken three times a day. Baseline walking distance is 5 meters. There is mention of functional capacity and therapeutic casmy. The remaining text is not available for proper evaluation.*
FDA Label Image

Figure 11 (Sildenafil For Oral Suspension 12)

FDA Label Image

Figure 12 (Sildenafil For Oral Suspension 13)

FDA Label Image

Gh (Sildenafil For Oral Suspension 14)

FDA Label Image

Figure B (Sildenafil For Oral Suspension 15)

FDA Label Image

Figure C (Sildenafil For Oral Suspension 16)

FDA Label Image

Figure D (Sildenafil For Oral Suspension 17)

FDA Label Image

Figure E (Sildenafil For Oral Suspension 18)

FDA Label Image

Figure F (Sildenafil For Oral Suspension 19)

FDA Label Image

Figure 2 (Sildenafil For Oral Suspension 2)

FDA Label Image

Figure G (Sildenafil For Oral Suspension 20)

FDA Label Image

1 (Sildenafil For Oral Suspension 21)

1 (Sildenafil For Oral Suspension 21)
This is a description for a medication called "GEFURE". It should be stored below 30°C (86°F) and should be protected from moisture. When reconstituted with 90mL of water, each mL of the suspension contains 10mg of sildenafil (as citrate). The medication comes in a grape flavor and should be shaken well before use. It should not be frozen and any unused portion should be discarded after 60 days. The usual dosage should be seen in the packaging insert for full prescribing information.*
FDA Label Image

1 (Sildenafil For Oral Suspension 22)

1 (Sildenafil For Oral Suspension 22)
Sildenafil is a medication available in grape-flavored suspension form that is taken orally. Before using, it must be reconstituted by adding water and shaking vigorously; instructions for doing so are included with the medication. Sildenafil is intended for oral use only and should be shaken well prior to each use. Proper storage is important; the medication should be kept below 30°C (86°F), either in the fridge or in its original package until reconstitution. Each mL of the suspension contains 10mg of sildenafil (as citrate) and there is 1.57g of sildenafil citrate (1.12g sildenafil) in each bottle. A dosing syringe and bottle adapter are included with the medication. This medication is distributed by Amneal Pharmaceuticals LLC, located in Bridgewater, NJ, and is available only by prescription. The medication's NDC number is 69238-1574-1. The text includes instructions for reconstitution, as well as dosage and storage information.*
FDA Label Image

Figure 3 (Sildenafil For Oral Suspension 3)

FDA Label Image

Figure 4 (Sildenafil For Oral Suspension 4)

FDA Label Image

Figure 5 (Sildenafil For Oral Suspension 5)

FDA Label Image

Figure 6 (Sildenafil For Oral Suspension 6)

FDA Label Image

Structural Formula (Sildenafil For Oral Suspension 7)

FDA Label Image

Figure- 7 (Sildenafil For Oral Suspension 8)

Figure- 7 (Sildenafil For Oral Suspension 8)
This is a table displaying drug interactions and recommended adjustments for certain drugs based on fold change and 90% confidence interval. The table lists drugs like Azithromycin, Bosentan, Cimetidine, Erythromycin, Maalox, Oral Contraceptives, Reonevit, and Saquinavir. The recommendations regarding dose adjustments and co-administration are strictly mentioned in the table. The last row of the table compares the change in effect of Sildenafil alone and with the interacting drugs mentioned earlier.*
FDA Label Image

Figure 8 (Sildenafil For Oral Suspension 9)

Figure 8 (Sildenafil For Oral Suspension 9)
This text provides recommendations for adjusting doses of various drugs based on their interaction with other drugs. It includes fold change and 90% confidence interval recommendations for several drugs including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin, Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir and Tolbutamide. The text also includes dosage adjustment recommendations for some drugs when coadministered with others. The last line refers to a graph displaying the change in drug effectiveness relative to the interacting drug alone.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.